Prostate Cancer - Results from #21560

Use of apparent diffusion coefficient as a response biomarker in bone: Effect of developing sclerosis on quantified values - Abstract December 20, 2013

Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer - Abstract December 20, 2013

No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period - Abstract December 20, 2013

Abiraterone acetate: A review of its use in patients with metastatic castration-resistant prostate cancer - Abstract December 20, 2013

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer - Abstract December 20, 2013

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cance - Abstract December 19, 2013

Comparison of positive surgical margin rates in high risk prostate cancer: Open versus minimally invasive radical prostatectomy - Abstract December 19, 2013

Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan - Abstract December 19, 2013

A case of primary seminal vesicle cancer detected by FDG-PET/CT - Abstract December 19, 2013

Potential implications on TCP for external beam prostate cancer treatment when considering the bystander effect in partial exposure scenarios - Abstract December 19, 2013

Tumor vascularity in prostate cancer: An update on circulating endothelial cells and platelets as noninvasive biomarkers - Abstract December 19, 2013

Is there a role for pelvic lymphadenectomy before radiation therapy in localized prostate carcinoma? - Abstract December 19, 2013

High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy - Abstract December 19, 2013

The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm(3)): Analysis of a cohort of 210 consecutive patients with low-risk disease - Abstract December 19, 2013

Bone mineral density in prostate cancer: A comparative study of patients with prostate cancer and healthy controls using propensity score matching - Abstract December 19, 2013

Differences in upgrading of prostate cancer in prostatectomies between community and academic practices - Abstract December 19, 2013

Intensity-modulated radiation therapy (IMRT) for localized and locally advanced prostate cancer: Initial result and morbidity - Abstract December 18, 2013

The expanding role of MRI in prostate cancer - Abstract December 18, 2013

A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial - Abstract December 18, 2013

Removal of limited nodal disease in patients undergoing radical prostatectomy: Long-term results confirm a chance for cure - Abstract December 18, 2013

Page 1079 of 1435